Repertoire and Pioneering Medicines, Flagship's in-house drug development unit, will jointly conduct research activities leveraging Repertoire's DECODE™ platform CAMBRIDGE, Mass., Dec. 22, 2025 ...

Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases with significant unmet ...

Pfizer is penning a cancer discovery pact with Cartography Biosciences that could max out at $865 million biobucks. | Pfizer ...

Pfizer's 2026 revenue midpoint of $61B and EPS midpoint of $2.90 decline YoY, reflecting persisting headwinds. Read more on ...

Pfizer reaffirmed its 2025 adjusted diluted EPS guidance of $3.00-$3.15, adding that revenue would land at roughly $62 billion (within the prior $61 billion-$64 billion range). Initial 2026 ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

Glioblastoma remains one of the most challenging solid tumors to treat due to its highly immunosuppressive tumor microenvironment.

The Huntersville Town Board Tuesday night unanimously backed a Charlotte developer’s planned $80 million Lake Norman mega-development near a proposed Red Line commuter rail station. The board agreed ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A trucking firm has purchased ...

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development Virtual Event ...